Announcements Trials
Browse Landscape

Phase

Phase 2 7Phase 1 7Phase 1/2 4Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 13Lymphoid 2Thoracic 1Plasma cell 1Myeloid 1Breast 1

Conditions

Lung Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Carcinogenesis 1

Interventions

Blood Specimen Collection 44Radiosurgery 41Early Intervention, Educational 33Standard of Care 31Exercise 30Educational Status 30Methods 28Drug Therapy 26Radiotherapy 23Magnetic Resonance Spectroscopy 23Surveys and Questionnaires 21Practice Guidelines as Topic 21X-Rays 17Pemetrexed 17Carboplatin 16Biopsy 16Tomography, X-Ray Computed 14Thoracic Surgery, Video-Assisted 14Therapeutics 12Fluorodeoxyglucose F18 12Interviews as Topic 11Gefitinib 11Cisplatin 11Specimen Handling 10Patient Navigation 10Cryosurgery 10anlotinib 9Surgical Procedures, Operative 9Psychiatric Rehabilitation 9Palliative Care 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Azacitidine × Thoracic × Clear all
NCT01209520 2015-02-24

Residual Hypermethylation in Early Stage Non-Small Cell Lung Cancer (NSCLC) As Part of Adjuvant Therapy and Preventive Strategy

University of Miami

Phase NA Completed
6 enrolled 6 charts
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Carcinogenesis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡